Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Bronchitis and Emphysema Advice and Training to Reduce Hospitalization

ClinicalTrials.gov ID: NCT00395083

Public ClinicalTrials.gov record NCT00395083. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 2:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CSP #560 - Bronchitis and Emphysema Advice and Training to Reduce Hospitalization (BREATH)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

EXECUTIVE SUMMARY: Purpose: To evaluate the efficacy and cost-effectiveness of a novel intervention incorporating self-management education, an action plan, and case-management to decrease the risk of hospitalizations due to chronic obstructive pulmonary disease (COPD) among veterans with severe COPD. Hypotheses: Primary Hypothesis: Veterans with COPD who receive a self-management program incorporating education sessions, development of an action plan, and case-management will have a decreased risk of COPD hospitalization compared to standardized COPD care. Primary Objective: In an intent-to-treat analysis, determine the efficacy of a comprehensive self-management program for reducing the risk of COPD hospitalization in veterans with severe COPD in comparison to patients receiving standardized COPD care. Secondary Hypotheses: Compared with standardized COPD care, veterans with COPD who receive a comprehensive self-management intervention will have: A) decreased health-related costs resulting from decreased hospitalizations and outpatient utilization, B) decreased hospitalization rates and average length of stay due to both COPD and all-cause admissions, and C) improvement in a set of outcomes including mortality, health-related quality of life, medication adherence, patient satisfaction, disease knowledge, skill acquisition and self-efficacy. Secondary Objectives: To evaluate the healthcare costs, hospitalization days, mortality, adherence, and health outcomes of a comprehensive self-management program compared to standardized COPD care among patients with severe COPD measured by: A)Healthcare-related costs B)Health services use due to COPD and to all causes C)Clinical outcome measures 1. Mortality 2. Health-related quality of life measured by generic and COPD-specific measures 3. Patient satisfaction 4. Medication adherence 5. Disease knowledge, skill acquisition and self-efficacy In the proposed study, 960 veterans with severe COPD hospitalized in the previous year will be randomly assigned to either a comprehensive case management program or standardized COPD care. The comprehensive group will receive an initial, intense education program with development of an action plan, and regular telephone contacts by a case manager in addition to standardized COPD care. Patients allocated to the control arm will receive standardized care that incorporates guideline-based recommendations including influenza vaccination, a short-acting bronchodilator, and either a long-acting bronchodilator or inhaled corticosteroid inhaler. The study will be conducted in 2 phases, a 12-month feasibility study conducted at 6 VA sites followed by the full study in which an additional 8 sites will enroll patients over the next 24 months. As a result, 180 patients will be initially enrolled in the feasibility study over the first year and the remaining 780 patients will be enrolled in the second and third years of the study when the full study is implemented. Subjects will be followed until the completion of the study, for at least one, and up to four years. The primary outcome is time to first COPD hospitalization.

Study identification

NCT ID
NCT00395083
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
426 participants

Conditions and interventions

Interventions

Behavioral

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2006
Primary completion
Aug 31, 2010
Completion
Aug 31, 2010
Last update posted
Sep 14, 2014

2006 – 2010

United States locations

U.S. sites
22
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Carl T. Hayden VA Medical Center Phoenix Arizona 85012
Southern Arizona VA Health Care System, Tucson Tucson Arizona 85723
VA Medical Center, Loma Linda Loma Linda California 92357
VA Palo Alto Health Care System Palo Alto California 94304-1290
VA Medical Center, Bay Pines Bay Pines Florida 33708
North Florida/South Georgia Veterans Health System Gainesville Florida 32608
Atlanta VA Medical and Rehab Center, Decatur Decatur Georgia 30033
Richard Roudebush VA Medical Center, Indianapolis Indianapolis Indiana 46202-2884
Robert J. Dole VAMC & ROC, Wichita Wichita Kansas 67218
VA Medical Center, Lexington Lexington Kentucky 40502
VA Medical Center, Kansas City MO Kansas City Missouri 64128
New Mexico VA Health Care System, Albuquerque Albuquerque New Mexico 87108-5153
VA Western New York Healthcare System at Buffalo Buffalo New York 14215
New York Harbor HCS New York New York 10010
VA Medical Center, Cincinnati Cincinnati Ohio 45220
VA Medical Center, Oklahoma City Oklahoma City Oklahoma 73104
VA Medical Center, Providence Providence Rhode Island 02908
VA North Texas Health Care System, Dallas Dallas Texas 75216
Michael E. DeBakey VA Medical Center (152) Houston Texas 77030
VA South Texas Health Care System, San Antonio San Antonio Texas 78229
Hunter Holmes McGuire VA Medical Center Richmond Virginia 23249
VA Puget Sound Health Care System Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00395083, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 14, 2014 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00395083 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →